444 90. Calafiore R, Basta G, Luca G, et al. Alginate/polyaminoacidic coherent microcapsules for pancreatic islet graft immunoisolation in diabetic recipients. Ann N YAcad Sci. 1997;831:313–22. 91. Soon-Shiong P, Feldman E, Nelson R, et al. Long-term reversal of diabetes by injection of immunoprotected islets. Proc Natl Acad Sci U S A. 1993;90:5843–7. 92. Soon-Shiong P, Heintz RE, Merideth N, et al. Insulin indepen- dence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet. 1994;343(8903):950–1. 93. Figliuzzi M, Plati T, Cornolti R, et al. Biocompatibility and function of microencapsulated pancreatic islets. Acta Biomater. 2006;2(2):221–7. 94. Safley SA, Kapp JA, Weber CJ. Proliferative and cytokine responses in CTLA4-Ig-treated diabetic NOD mice transplanted with microencap- sulated neonatal porcine ICCs. Cell Transplant. 2002;11(7):695–705. Curr Diab Rep (2011) 11:434–444 95. Safley SA, Kapp LM, Tucker-Burden C, et al. Inhibition of cellular immune responses to encapsulated porcine islet xenografts by simultaneous blockade of two different costimulatory path- ways. Transplantation. 2005;79(4):409–18. 96. Cui H, Tucker-Burden C, Cauffiel SMD, et al. Long-term metabolic control of autoimmune diabetes in spontaneously diabetic nonobese diabetic mice by nonvascularized microencap- sulated adult porcine islets. Transplantation. 2009;88(2):160–9. 97. Calafiore R, Basta G, Luca G, et al. Grafts of microencapsulated pancreatic islet cells for the therapy of diabetes mellitus in non- immunosuppressed animals. Biotechnol Appl Biochem. 2004;39 (23):159–64. 98. Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol. 2005;23(1):47–55.